Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 16 studies | 34% ± 17% | |
pericyte | 14 studies | 32% ± 17% | |
connective tissue cell | 9 studies | 38% ± 15% | |
myofibroblast cell | 6 studies | 42% ± 17% | |
smooth muscle cell | 6 studies | 25% ± 7% | |
adventitial cell | 4 studies | 43% ± 5% |
Insufficient scRNA-seq data for expression of CD248 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 18401.01 | 453 / 459 | 97% | 67.89 | 1084 / 1118 |
skin | 93% | 13927.18 | 1677 / 1809 | 89% | 51.20 | 420 / 472 |
lung | 84% | 4282.52 | 487 / 578 | 93% | 50.44 | 1072 / 1155 |
thymus | 89% | 4424.76 | 582 / 653 | 87% | 32.01 | 528 / 605 |
bladder | 90% | 7631.86 | 19 / 21 | 84% | 50.89 | 425 / 504 |
uterus | 96% | 6567.40 | 164 / 170 | 78% | 66.99 | 356 / 459 |
esophagus | 78% | 4494.13 | 1133 / 1445 | 93% | 50.59 | 170 / 183 |
intestine | 78% | 3514.71 | 756 / 966 | 92% | 60.78 | 485 / 527 |
ovary | 80% | 2625.64 | 144 / 180 | 73% | 29.85 | 312 / 430 |
stomach | 50% | 2423.10 | 180 / 359 | 94% | 59.06 | 268 / 286 |
prostate | 69% | 1993.79 | 168 / 245 | 75% | 18.72 | 375 / 502 |
kidney | 61% | 1701.79 | 54 / 89 | 70% | 66.44 | 628 / 901 |
adrenal gland | 47% | 1088.50 | 122 / 258 | 69% | 37.36 | 159 / 230 |
pancreas | 15% | 320.39 | 50 / 328 | 97% | 121.17 | 173 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.34 | 1 / 1 |
adipose | 100% | 24861.83 | 1203 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 40.69 | 23 / 29 |
tonsil | 0% | 0 | 0 / 0 | 76% | 29.74 | 34 / 45 |
blood vessel | 73% | 3378.33 | 979 / 1335 | 0% | 0 | 0 / 0 |
heart | 63% | 1904.90 | 540 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 16.03 | 45 / 80 |
liver | 1% | 27.13 | 2 / 226 | 50% | 14.82 | 202 / 406 |
brain | 0% | 10.01 | 11 / 2642 | 42% | 22.95 | 294 / 705 |
muscle | 23% | 539.51 | 182 / 803 | 0% | 0 | 0 / 0 |
spleen | 14% | 267.40 | 33 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0048535 | Biological process | lymph node development |
GO_0010761 | Biological process | fibroblast migration |
GO_0008150 | Biological process | biological_process |
GO_0072577 | Biological process | endothelial cell apoptotic process |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0060033 | Biological process | anatomical structure regression |
GO_2000353 | Biological process | positive regulation of endothelial cell apoptotic process |
GO_0016477 | Biological process | cell migration |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_1990430 | Molecular function | extracellular matrix protein binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0050840 | Molecular function | extracellular matrix binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | CD248 |
Protein name | CD248 Endosialin (Tumor endothelial marker 1) (CD antigen CD248) |
Synonyms | CD164L1 TEM1 |
Description | FUNCTION: May play a role in tumor angiogenesis. . |
Accessions | A0A120HV04 ENST00000311330.4 [Q9HCU0-1] Q9HCU0 |